ACTIVE

VERZELE PHARMA ZWALM

Financial year 2025 · Closed on 31/12/2025

Net result17 k €-62,6 %over 1 year

Gross margin76,4 k €-45,2 %over 1 year

Equity183,3 k €+2,8 %over 1 year

Identity

Source · BCE/KBO

VERZELE PHARMA ZWALM is a Private limited company incorporated in 2001. Its main activity is: Dispensing chemist in specialised stores. Its registered office is in Oudenaarde.

Legal situation: Normal situation
BCE/KBO no. / VAT: BE 0475.231.407
Incorporation: 06/07/2001
Legal form: Private limited company
Registered office: Diependale 8
9700 Oudenaarde · FlandreSee on map
Contributed capital: 18 550,00 €
Latest accounts: 31/12/2025

Activities (NACE)

47730Dispensing chemist in specialised stores· main 47730Dispensing chemist in specialised stores 64200Activities of holding companies 64210Activities of holding companies 74151Specialised design activities 47730Dispensing chemist in specialised stores+1

Joint committees (1)

Signals

ProfitableSolid equityLow riskGood liquidityPositive cashflowPositive EBITDAHealthy social debts

Financials

Source · NBB, 20 filings

Trend over 20 financial years

	2025		2024		2023		2022		2021
Income statement
Gross margin	76,4 k €	-45.2%	139,5 k €	+20.7%	115,6 k €	-4.1%	120,6 k €	+11.6%	108 k €
EBITDA	27,9 k €	-54.4%	61,1 k €	+40.9%	43,4 k €	-25.1%	57,9 k €	+36.4%	42,4 k €
Operating result	17,7 k €	-59.6%	43,7 k €	+1737%	-2,7 k €	-120%	13,3 k €	+1327%	-1,1 k €
Net result	17 k €	-62.6%	45,5 k €	+13725%	-334,2 €	-103%	11,8 k €	+1071%	1 k €
Balance sheet
Equity	183,3 k €	+2.8%	178,2 k €	+5.7%	168,7 k €	-0.2%	169 k €	+7.5%	157,2 k €
Total assets	431,2 k €	-11.4%	486,9 k €	+0.1%	486,2 k €	+5.5%	460,8 k €	-8.0%	500,8 k €
Cash	87,4 k €	+2.5%	85,3 k €	+23.4%	69,2 k €	+66.9%	41,4 k €	-21.2%	52,6 k €
Debts	243,6 k €	-20.0%	304,4 k €	-2.9%	313,5 k €	+8.8%	288 k €	-14.9%	338,3 k €
Other
Workforce	–		–		–		1,0 ETP	-16.7%	1,2 ETP

Valuation

Indicative valuation

As an indication, this company is worth

between 100 k€ and 250 k€

See the valuation

Board of directors

Source · NBB, accounts to 31/12/2025

2 active · 5 ended

Active mandates

Conrad Pharma

Director · 0536.875.697

Represented by Vanessa Pluym

Active

Philippe Verzele

Director

Active

Ended mandates

Conrad Pharma

Manager · since 02 janvier 2019 · 0536.875.697

Represented by Vanessa Pluym

Ended

Philippe Verzele

Manager · since 02 janvier 2019

Ended

Antoine De Beule

Manager · since 03 janvier 2011 · until 03 janvier 2016

Ended

Simone Hoornaert

Manager · since 04 juillet 2001

Ended

Other companies at this address

Diependale 8 9700 Oudenaarde

Company	CBE no.
Conrad Pharma● Active	0536.875.697
DECAPHAR● Active	0843.302.261
GEVA PHARMA● Active	0427.597.576
VERZELE PHARMA● Active	0896.764.703

Full financial information

Source · NBB

	2025	2024	2023	2022	2021	2020
Type of account	Micro model	Micro model	Micro model	Abridged model	Abridged model	Abridged model
Start of the financial year	01/01/2025	01/01/2024	01/01/2023	01/01/2022	01/01/2021	01/01/2020
Closing of the financial year	31/12/2025	31/12/2024	31/12/2023	31/12/2022	31/12/2021	31/12/2020
Length of the financial year	12 months	12 months	12 months	12 months	12 months	12 months
Filing date	28/08/2026	08/08/2025	12/07/2024	05/07/2023	24/08/2022	26/08/2021
General meeting	24/08/2026	07/08/2025	26/06/2024	28/06/2023	16/08/2022	29/01/2021
Currency of the financial year	EUR	EUR	EUR	EUR	EUR	EUR
NBB quality label	Satisfying controls	Satisfying controls	Satisfying controls	Satisfying controls	Satisfying controls	Satisfying controls

Financial ratios

Source · NBB

Looking for more information about this company?

Try for free

Annual accounts filings

Source · NBB, 20 filings

Model	Closing	General meeting	Filed	Language	Document
Micro model	31/12/2025	24/08/2026	28/08/2026	Dutch	PDF
Micro model	31/12/2024	07/08/2025	08/08/2025	Dutch	PDF
Micro model	31/12/2023	26/06/2024	12/07/2024	Dutch	PDF
Abridged model	31/12/2022	28/06/2023	05/07/2023	Dutch	PDF
Abridged model	31/12/2021	16/08/2022	24/08/2022	Dutch	PDF
Abridged model	31/12/2020	29/01/2021	26/08/2021	Dutch	PDF
Abridged model	31/12/2019	27/08/2020	14/09/2020	Dutch	PDF
Abridged model	31/12/2018	30/08/2019	30/08/2019	Dutch	PDF
Abridged model	31/12/2017	25/05/2018	19/06/2018	Dutch	PDF
Abridged model	31/12/2016	30/06/2017	27/07/2017	Dutch	PDF
Abridged model	31/12/2015	30/06/2016	03/08/2016	Dutch	PDF
Abridged model	31/12/2014	30/06/2015	22/09/2015	Dutch	PDF
Abridged model	31/12/2013	30/06/2014	29/08/2014	Dutch	PDF
Abridged model	31/12/2012	31/05/2013	13/06/2013	Dutch	PDF
Abridged model	31/12/2011	30/06/2012	31/08/2012	Dutch	PDF
Abridged model	31/12/2010	30/06/2011	18/07/2011	Dutch	PDF
Abridged model	31/12/2009	30/06/2010	06/07/2010	Dutch	PDF
Abridged model	31/12/2008	20/06/2009	16/07/2009	Dutch	PDF
Abridged model	31/12/2007	30/05/2008	10/06/2008	Dutch	PDF
Abridged model	31/12/2006	27/06/2007	02/07/2007	Dutch	PDF

Indicative valuation

Order of magnitude

As an indication, this company is worth

between 100 k€ and 250 k€

The detail comes with the Business plan: low and high bounds, the valuation bridge for each financial year, transaction multiples by sector and size, group valuation and exports.

Discover the Business plan

Disclaimer

Indicative estimate based on public sector multiples and the filed annual accounts. It is neither a certified valuation nor financial or investment advice.

Board of directors

Source · NBB, accounts to 31/12/2025

2 active · 5 ended

Active mandates

Conrad Pharma

Director · 0536.875.697

Represented by Vanessa Pluym

Active

Philippe Verzele

Director

Active

Ended mandates

Conrad Pharma

Manager · since 02 janvier 2019 · 0536.875.697

Represented by Vanessa Pluym

Ended

Philippe Verzele

Manager · since 02 janvier 2019

Ended

Antoine De Beule

Manager · since 03 janvier 2011 · until 03 janvier 2016

Ended

Simone Hoornaert

Manager · since 04 juillet 2001

Ended

Ownership and network

Looking for more information about this company?

Try for free

Belgian Official Gazette publications

Source · Belgian Official Gazette

Mandates24/01/2024
STATUTEN (VERTALING, COÖRDINATIE, OVERIGE WIJZIGINGEN, ) - WIJZIGING RECHTSVORM - DOEL - ONTSLAGEN - BENOEMINGEN
PDF
Mandates18/01/2019
BENAMING - MAATSCHAPPELIJKE ZETEL - DOEL - ONTSLAGEN - BENOEMINGEN - ALGEMENE VERGADERING
PDF
Restructuring17/01/2019
BENAMING - MAATSCHAPPELIJKE ZETEL - KAPITAAL - AANDELEN - STATUTEN (VERTALING, COÖRDINATIE, OVERIGE WIJZIGINGEN, ) - RUBRIEK HERSTRUCTURERING (FUSIE, SPLITSING, OVERDRACHT VERMOGEN, ENZ...)
PDF
Restructuring27/11/2018
RUBRIEK HERSTRUCTURERING (FUSIE, SPLITSING, OVERDRACHT VERMOGEN, ENZ...)
PDF
Mandates18/02/2016
ONTSLAGEN - BENOEMINGEN
PDF
Mandates22/04/2011
ONTSLAGEN - BENOEMINGEN
PDF

Similar companies

A company's peers, by sector and size, are included in the Business plan.

See the Business plan

Timeline

2025
Annual accounts 202517 k €↓
2024
Annual accounts 202445,5 k €↑
2023
Annual accounts 2023-334,2 €↓
2022
Annual accounts 202211,8 k €↑
2021
Annual accounts 20211 k €↓
2020
Annual accounts 20209,6 k €↑
2019
Annual accounts 2019-5,5 k €↓
2018
Annual accounts 201844,1 k €↑
2017
Annual accounts 201733 k €↑
2016
Annual accounts 20166,9 k €↓
2015
Annual accounts 201529,4 k €↑
2014
Annual accounts 2014-76,7 k €↓
2013
Annual accounts 2013-11,7 k €↓
2012
Annual accounts 2012-2,7 k €↑
2011
Annual accounts 2011-13,9 k €↓
2010
Annual accounts 2010-253,3 €↓
2009
Annual accounts 20093,2 k €↑
2008
Annual accounts 2008-2,1 k €↓
2007
Annual accounts 20071,9 k €↓
2006
Annual accounts 20067,9 k €
06/07/2001
IncorporationPrivate limited company

VERZELE PHARMA ZWALM

Overview

Identity

Financials

Valuation

Indicative valuation

Board of directors

Other companies at this address

Financials

Full financial information

Financial ratios

Annual accounts filings

Valuation

Indicative valuation

Directors & structure

Board of directors

Ownership and network

Publications

Belgian Official Gazette publications

Similar companies

Similar companies

Timeline

Timeline